Provectus Biopharmaceuticals' Phase 1 PV-10 Data on Liver Cancer Presented at 6th Asia-Pacific Primary Liver Cancer Expert Meeting
July 06, 2015 at 08:03 AM EDT
Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com ), a clinical-stage oncology and dermatology biopharmaceutical ...